Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder

被引：9

作者：

Pandina, Gahan ^{[1
]}

Ring, Robert H. ^{[2
,3
]}

Bangerter, Abigail ^{[1
]}

Ness, Seth ^{[1
]}

机构：

[1] Janssen Res & Dev LLC, 1125 Trenton Harbouron Rd, Titusville, NJ 08560 USA

[2] Kaerus Biosci Ltd, London, England

[3] 2110 South Eagle Rd,Suite 392, Newtown, PA 18940 USA

来源：

PSYCHIATRIC CLINICS OF NORTH AMERICA | 2020年 / 43卷 / 04期

关键词：

ASD; Autism; Drug development; Therapeutics; Clinical trials; SOCIAL-BEHAVIOR; ENDOCANNABINOID SYSTEM; REPETITIVE BEHAVIORS; EARLY-CHILDHOOD; MOUSE MODEL; CHILDREN; OXYTOCIN; ADOLESCENTS; ADULTS; BRAIN;

D O I：

10.1016/j.psc.2020.08.003

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

There are no approved medications for autism spectrum disorder (ASD) core symptoms. However, given the significant clinical need, children and adults with ASD are prescribed medication off label for core or associated conditions, sometimes based on limited evidence for effectiveness. Recent developments in the understanding of biologic basis of ASD have led to novel targets with potential to impact core symptoms, and several clinical trials are underway. Heterogeneity in course of development, cooccurring conditions, and age-related treatment response variability hampers study outcomes. Novel measures and approaches to ASD clinical trial design will help in development of effective pharmacologic treatments.

引用

页码：629 / +

页数：18

共 50 条

[31] The Role of Diagnostic Instruments in Dual and Differential Diagnosis in Autism Spectrum Disorder Across the Lifespan
Shulman, Cory
Rice, Catherine E.
Morrier, Michael J.
Esler, Amy
[J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2020, 43 (04) : 605 - +
[32] The Role of Diagnostic Instruments in Dual and Differential Diagnosis in Autism Spectrum Disorder Across the Lifespan
Shulman, Cory
Rice, Catherine E.
Morrier, Michael J.
Esler, Amy
[J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2020, 29 (02) : 275 - +
[33] Nursing of Autism Spectrum Disorder: Evidence-Based Integrated Care Across The Lifespan
Beebe, Lora Humphrey
[J]. ISSUES IN MENTAL HEALTH NURSING, 2013, 34 (08) : 631 - 631
[34] Types of strain among family members of individuals with autism spectrum disorder across the lifespan
Shivers, Carolyn M.
Krizova, Katarina
Lee, Gloria K.
[J]. RESEARCH IN DEVELOPMENTAL DISABILITIES, 2017, 68 : 42 - 51
[35] EYE GAZE PREFERENCE FOR SOCIAL SCENES IN AUTISM SPECTRUM DISORDER: DIFFERENCES ACROSS THE LIFESPAN
Shaffer, Rebecca
Adams, Ryan
Hong, Michael
Erickson, Craig A.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S264 - S264
[36] Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder
Robyn P. Thom
Joseph A. Pereira
Danielle Sipsock
Christopher J. McDougle
[J]. Current Psychiatry Reports, 2021, 23
[37] Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder
Thom, Robyn P.
Pereira, Joseph A.
Sipsock, Danielle
McDougle, Christopher J.
[J]. CURRENT PSYCHIATRY REPORTS, 2021, 23 (12)
[38] PHARMACOLOGICAL TREATMENTS FOR THE CORE SYMPTOMS OF AUTISM SPECTRUM DISORDER: A SYSTEMATIC REVIEW
Clevenger, Steven
Palffy, Alexander
Popescu, Razvan
[J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2021, 60 (10): : S161 - S162
[39] Drug repurposing candidates to treat core symptoms in autism spectrum disorder
Koch, Elise
Demontis, Ditte
[J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
[40] Unexpected improvement in core autism spectrum disorder symptoms after long-term treatment with probiotics
Grossi, Enzo
Melli, Sara
Dunca, Delia
Terruzzi, Vittorio
[J]. SAGE OPEN MEDICAL CASE REPORTS, 2016, 4

← 1 2 3 4 5 →